Lv4
464 积分 2024-08-20 加入
Innate lymphoid cells in pancreatic ductal adenocarcinoma: Immune regulation and therapeutic implications
15小时前
已完结
MAVS in Cancer Therapy: The New STING?
15小时前
已关闭
Turning cold tumors hot: from molecular mechanisms to clinical applications
15小时前
已完结
Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer
2天前
已完结
Neoadjuvant nab-paclitaxel plus gemcitabine followed by modified FOLFIRINOX for resectable pancreatic cancer: A randomized phase 3 trial
2天前
已完结
Immunotherapy for extensive-stage small cell lung cancer: current status, challenges and future strategies
1个月前
已完结
Overexpression of MicroRNA-122 Re-sensitizes 5-FU-Resistant Colon Cancer Cells to 5-FU Through the Inhibition of PKM2 In Vitro and In Vivo
2个月前
已完结
PRODIGE 29-UCGI 26 (NEOPAN): A Phase III Randomized Trial Comparing Chemotherapy With FOLFIRINOX or Gemcitabine in Locally Advanced Pancreatic Carcinoma
2个月前
已完结
Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study
2个月前
已完结
The gut microbiome as a target in cancer immunotherapy: opportunities and challenges for drug development
3个月前
已完结
皖公网安备34019202002308
